![conference banner](/images/conference-banner.jpeg)
Abstract
Background: Colon cancer is one of the most common cancers worldwide and has a poor prognosis. Through the analysis of transcriptome and clinical data of colon cancer, an immune gene-set signature was identified by single sample enrichment analysis (ssGSEA) scoring to predict patient survival and discover new therapeutic targets.
Objective: To study the role of immune gene-set signature in colon cancer.
Methods: First, RNASeq and clinical follow-up information were downloaded from The Cancer Genome Atlas (TCGA). Immune gene-related gene sets were collected from the ImmPort database. Genes and immunological pathways related to prognosis were screened in the training set and integrated for feature selection using random forest. The immune gene-related prognosis model was verified in the entire TCGA test set and GEO validation set and compared with immune cells scores and matrix score.
Results: A total of 1650 prognostic genes and 13 immunological pathways were identified. These genes and pathways are closely related to the development of tumors. 13-immune gene-set signature was established, which is an independent prognostic factor for patients with colon cancer. Risk stratification of samples could be carried out in the training set, test set, and external validation set. The AUC of five-year survival in the training set and validation set is greater than 0.6. Immunosuppression occurs in high-risk samples and compared with published models, riskScore has a better prediction effect.
Conclusion: This study constructed a 13-immune gene-set signature as a new prognostic marker to predict the survival of patients with colon cancer, and provided new diagnostic/prognostic biomarkers and therapeutic targets for colon cancer.
Keywords: Bioinformatics, prognostic markers, TCGA, colon cancer, biomarker, cell mutation.
Combinatorial Chemistry & High Throughput Screening
Title:A 13-Immune Gene Set Signature for Prediction of Colon Cancer Prognosis
Volume: 24 Issue: 8
Author(s): Zhuo Lu, Jin Chen, JiongYi Yan, QiaoMing Liu, Fang Li, WanNa Xiong, Shida Lin, Kai Yu* Jianqin Liang*
Affiliation:
- College of Life Science and Technology, Guangxi University, Nanning, Nanning, 530004,China
- Department of Pharmacy, Guangxi University of Traditional Chinese Medicine, Nanning City, Guangxi Province, 530001,China
Keywords: Bioinformatics, prognostic markers, TCGA, colon cancer, biomarker, cell mutation.
Abstract:
Background: Colon cancer is one of the most common cancers worldwide and has a poor prognosis. Through the analysis of transcriptome and clinical data of colon cancer, an immune gene-set signature was identified by single sample enrichment analysis (ssGSEA) scoring to predict patient survival and discover new therapeutic targets.
Objective: To study the role of immune gene-set signature in colon cancer.
Methods: First, RNASeq and clinical follow-up information were downloaded from The Cancer Genome Atlas (TCGA). Immune gene-related gene sets were collected from the ImmPort database. Genes and immunological pathways related to prognosis were screened in the training set and integrated for feature selection using random forest. The immune gene-related prognosis model was verified in the entire TCGA test set and GEO validation set and compared with immune cells scores and matrix score.
Results: A total of 1650 prognostic genes and 13 immunological pathways were identified. These genes and pathways are closely related to the development of tumors. 13-immune gene-set signature was established, which is an independent prognostic factor for patients with colon cancer. Risk stratification of samples could be carried out in the training set, test set, and external validation set. The AUC of five-year survival in the training set and validation set is greater than 0.6. Immunosuppression occurs in high-risk samples and compared with published models, riskScore has a better prediction effect.
Conclusion: This study constructed a 13-immune gene-set signature as a new prognostic marker to predict the survival of patients with colon cancer, and provided new diagnostic/prognostic biomarkers and therapeutic targets for colon cancer.
Export Options
About this article
Cite this article as:
Lu Zhuo , Chen Jin , Yan JiongYi , Liu QiaoMing , Li Fang, Xiong WanNa, Lin Shida , Yu Kai *, Liang Jianqin *, A 13-Immune Gene Set Signature for Prediction of Colon Cancer Prognosis, Combinatorial Chemistry & High Throughput Screening 2021; 24 (8) . https://dx.doi.org/10.2174/1386207323666200930104744
DOI https://dx.doi.org/10.2174/1386207323666200930104744 |
Print ISSN 1386-2073 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5402 |
Call for Papers in Thematic Issues
Artificial Intelligence Methods for Biomedical, Biochemical and Bioinformatics Problems
Recently, a large number of technologies based on artificial intelligence have been developed and applied to solve a diverse range of problems in the areas of biomedical, biochemical and bioinformatics problems. By utilizing powerful computing resources and massive amounts of data, methods based on artificial intelligence can significantly improve the ...read more
Exploring Spectral Graph Theory in Combinatorial Chemistry
Combinatorial chemistry involves the synthesis and analysis of a large number of diverse compounds simultaneously. Traditional methods rely on brute-force experimentation, which can be time-consuming and resource-intensive. Spectral graph theory, a branch of mathematics dealing with the properties of graphs in relation to the eigenvalues and eigenvectors of matrices associated ...read more
![Wayfinder Image](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Focus on the Multimodal Role of Biomarkers in Breast Cancer
Current Pharmaceutical Design The Application of Micro-Analytical Techniques to Biomedical Analysis
Current Pharmaceutical Analysis The Association Between the Chronic Use of Non-Steroidal Anti- Inflammatory Drugs and Oxidative and Inflammatory Markers in the Elderly
Inflammation & Allergy - Drug Targets (Discontinued) Synthesis and Biological Evaluation of 2-methoxy-N-phenyl-6-(5-phenyl-1, 3,4-oxadiazol-2-yl) pyridin-3-amine Derivatives as Antimicrobial Agents
Letters in Organic Chemistry Recent Advances in Mesoporous Silica and Gold Based Nanovectors in Anticancer Drug Delivery System
Current Organic Chemistry Emerging Trends in Abuse-Deterrent Formulations: Technological Insights and Regulatory Considerations
Current Drug Delivery Coumarins as Potential Inhibitors of DNA Polymerases and Reverse Transcriptases. Searching New Antiretroviral and Antitumoral Drugs
Current Drug Discovery Technologies Can Surgery for Inflammatory Bowel Disease be Personalized?
Current Drug Targets Liposomes: Targeted and Controlled Delivery System
Drug Delivery Letters Meet Our Editorial Board Member
Current Regenerative Medicine (Discontinued) Recent Advancement in Topical Drug Delivery for Psoriasis: Clinical Pertinence and Potential Market
Current Drug Targets ANN and Bayesian Classification Models for Virtual Screening of Endocrine-Disrupting Chemicals
Combinatorial Chemistry & High Throughput Screening Peptide-Based Nanoparticle for Ex Vivo and In Vivo Dug Delivery
Current Pharmaceutical Design Development of Promising Thiopyrimidine-Based Anti-cancer and Antimicrobial Agents: Synthesis and QSAR Analysis
Mini-Reviews in Medicinal Chemistry Application of Proteomic Tools in Modern Nanotechnological Approaches Towards Effective Management of Neurodegenerative Disorders
Current Drug Metabolism Artificial Intelligence, Big Data and Machine Learning Approaches in Precision Medicine & Drug Discovery
Current Drug Targets DPP-Cu<sup>2+</sup> Complexes Gated Mesoporous Silica Nanoparticles For pH and Redox Dual Stimuli-Responsive Drug Delivery
Current Medicinal Chemistry LPA and its Analogs-Attractive Tools for Elucidation of LPA Biology and Drug Development
Current Medicinal Chemistry Apoptotic and Antiproliferative Potential of GAPDH from <i>Mallotus philippensis</i> Seed on Human Lung Carcinoma: <i>In Vitro</i> and <i>In Vivo</i> Approach
Protein & Peptide Letters Membrane Domains and the “Lipid Raft” Concept
Current Medicinal Chemistry